SCHEMBL13009116

SCHEMBL13009116

c1ccc(-c2c3ccc(N4c5ccccc5Cc5ccccc54)cc3c(-c3cccc(-c4cccc5ccccc45)c3)c3ccc(N4c5ccccc5Cc5ccccc54)cc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.33
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
NFKB2 Q00653 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426945 0.98 POLB (0.34) PDE6DMCL1ACMSDCTDSP1HPGD
SCHEMBL13008793 0.95 POLB (0.33) PDE6DMCL1ACMSDCTDSP1HPGD
SCHEMBL13009118 0.94 PDE6D (0.36) PDE6DMCL1ACMSDCTDSP1HPGD
SCHEMBL13009022 0.93 PDE6D (0.33) PDE6DMCL1ACMSDHPGDPOLB
SCHEMBL13008789 0.93 PDE6D (0.34) PDE6DCTDSP1HPGDPOLBKDM4E
SCHEMBL13009393 0.93 PDE6D (0.34) PDE6DCTDSP1HPGDPOLBKDM4E
SCHEMBL13426993 0.92 MET (0.39) PDE6DMCL1ACMSDHPGDPOLB
SCHEMBL13008783 0.92 POLB (0.35) PDE6DMCL1ACMSDCTDSP1HPGD
SCHEMBL13008620 0.91 PDE6D (0.38) PDE6DMCL1ACMSDCTDSP1HPGD
SCHEMBL13009315 0.91 PDE6D (0.33) PDE6DCTDSP1HPGDPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PDE6D 3559/4885MCL1 3232/4885ACMSD 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.